In This Section

Program

Saturday, November 7

EDUCATION SESSION
4-5:30 PM

Douglas A. Levine, NYU Langone Health, New York, New York

Blake Gilks, Vancouver Coastal Health Research Institute, Vancouver, British Columbia, Canada

Victoria Bae-Jump, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina

BREAK AND WELCOME
5:30-6 pm
OPENING KEYNOTE
6-7:00 PM      

Recent progress with PTEN
Ramon Parsons, Icahn School of Medicine at Mount Sinai, New York, New York

OPENING RECEPTION / POSTER SESSION A
7 PM-8:30 PM

Sunday, NoveMBER 8

CONTINENTAL BREAKFAST
7-8:00 AM   
PLENARY SESSION 1: Molecular Stratification
8-10:00 AM      

Title to be announced
Naveena Singh, Barts Health NHS Trust, London, England

Title to be announced
Jessica N. McAlpine, University of British Columbia, Vancouver, British Columbia, Canada

Additional speaker to be announced

Short talks from proffered abstracts

BREAK
10-10:30 AM  
 PLENARY SESSION 2: DNA Repair and Replication
10:30 AM-12:30 PM  

POLE mutations in endometrial cancer: Consequences and mechanisms
Polina V. Shcherbakova, University of Nebraska, Lincoln, Nebraska

Defective DNA mismatch repair: Where to in management of endometrial cancer
Paul Goodfellow, Ohio State University, Columbus, Ohio

Title to be announced
Tjalling Bosse, Leiden University Medical Center, Leiden, Netherlands

Short talks from proffered abstracts

 FREE TIME / LUNCH ON OWN
12:30 PM-1:30 PM
PLENARY SESSION 3: Functional Genomics and Proteomics
1:30 PM-3:30 PM                            

Mismatch repair deficiency and survival in Stage I endometrial Cancer
Russell R. Broaddus, The University of Texas MD Anderson Cancer Center, Houston, Texas

Proteogenomic Characterization of Endometrial Carcinoma                                                               
David Fenyo, NYU Langone Health, New York, New York

Additional speaker to be announced

Short talks from proffered abstracts

BREAK
3:30 PM-4 PM                            
PLENARY SESSION 4: Novel Model Systems
4-6:00 PM 

Title to be announced
Victoria Bae-Jump, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina

Title to be announced
Stephen D. Hursting, University of North Carolina Chapel Hill, Chapel Hill, North Carolina

Organoids to model endometrial carcinoma subtypes 
David G. Huntsman, British Columbia Cancer Research Center, Vancouver, British Columbia, Canada

Chromatin regulation of the endometrium: What are our models telling us?Ronald L. Chandler, Michigan State University, East Lansing, Michigan

POSTER SESSION B / RECEPTION
6-7:30 PM                            

MONDAY, NOVEMBER 9, 2020

CONTINENTAL BREAKFAST
7-8:00 AM                           
PLENARY SESSION 5: Immunotherapy
8-10:00 AM                         

Immunology of endometrial cancers: tumor genetics, immune recognition, and immunotherapy response
Dmitriy Zamarin, Memorial Sloan Kettering Cancer Center, New York, New York

Coordinated T and B cell responses exert immune pressure against malignant progression 
Jose R. Conejo-Garcia, Moffitt Cancer Center, Tampa, Florida

Title to be announced
Alexandra Snyder, Merck Oncology, Rahway, New Jersey

Short talks from proffered abstracts

BREAK
10-10:30 AM                      
PLENARY SESSION 6: Targeted Therapeutics
10:30 AM-12:30 PM                      

DNA Damaging Agents in Endometrial Cancer
Shannon Neville Westin, The University of Texas MD Anderson Cancer Center, Houston, Texas

Title to be announced
Helen J. MacKay, Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Novel antibody-drug conjugates (ADC) for the targeted treatment of endometrial cancer                                                               
Alessandro D. Santin, Yale University, New Haven, Connecticut

Additional speaker to be announced

CLOSING REMARKS / DEPARTURE
12:30 PM